Lisata Therapeutics and Kuva Labs have announced a worldwide partnership and licence agreement to develop a new class of advanced magnetic resonance (MR) imaging agents for solid tumour detection.

Methane emission reduction solutions provider Kuva Systems has been granted a $5m contract by the US Department of Energy's ...

Don’t miss out on full articles and exclusive content that can propel your career and projects forward. Register now to unlock premium content from Imaging and Machine Vision Europe. Oliver Grass, ...